FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912572866> ?p ?o ?g. }

• W2912572866 abstract "Background. Partial agonists of α4b2 nicotinic acetylcholine receptors are the most effective treatment strategy for tobacco smoking cessation. They are able to alleviate withdrawal symptoms and to reduce smoking satisfaction.&#x0D; The aim of this study was to review the efficacy and safety of nicotinic receptor partial agonists varenicline and cytisine, for smoking cessation.&#x0D; Methods. A search for randomized controlled trials was done using the terms (“cytisine”, “tabex”, “varenicline” or 'partial agonists of nicotinic receptors’) in MEDLINE, EMBASE, eLibrary in May 2018. Types of participants, the doses and duration of the treatments, efficacy and safety parameters, quality of randomization and blinding procedures were evaluated. Bayesian network meta-analysis was performed.&#x0D; Results. Cytisine overcame placebo in the 12, 24 and 52 weeks of therapy with the following odds ratios (ORs) for abstinence: 3.3 (95% CrI 1.8–5.8), 3.9 (2.4–6.7), 3.8 (CrI 1.3–11,9) accordingly. Varenicline in 2 mg/day dose overcame placebo in the 12, 24 and 52 weeks of therapy with the ORs: 4.0 (3.3–4.7), 3.1 (2.5–3.7), 2.9 (2.2–4.1) accor dingly. Varenicline in 1 mg/day dose overcame placebo in 12 and 52 weeks of therapy, the ORs were 3.0 (2.0–4.7) and 2.3 (1.3–4.4) accordingly. Varenicline in 0.5 mg/day dose overcame placebo in 12 weeks of therapy only with the OR 2.4 (1.3–4.4). Cytisine and varenicline 2 mg/day were associated with more gastrointestinal disturbances than placebo with the ORs 6.2 (2.1–22.8) and 2.4 (2.0–2.8) accordingly. Cytisine and varenicline 2 mg/day were associated with more psychiatric problems than placebo with ORs 5.2 (1.9–15.1) and 1.6 (1.3–1.9) accordingly. There was no difference in serious adverse events between the investigated drugs and placebo: OR for cytisine was 2.4 (0.8–6.8), varenicline 0.5 mg/day – 2.0 (0.5–6.6), varenicline 1.0 mg/day – 1.0 (0.3–2.7), varenicline 2 mg/day – 1.0 (0.7–1.4).&#x0D; Conclusion. Cytisine was proved to be as effective and safe aid for smoking cessation as varenicline." @default.
• W2912572866 created "2019-02-21" @default.
• W2912572866 creator A5009020541 @default.
• W2912572866 creator A5009392255 @default.
• W2912572866 creator A5012373483 @default.
• W2912572866 creator A5025595554 @default.
• W2912572866 creator A5034582838 @default.
• W2912572866 creator A5036753856 @default.
• W2912572866 creator A5049130433 @default.
• W2912572866 creator A5062896883 @default.
• W2912572866 creator A5063389899 @default.
• W2912572866 creator A5085603489 @default.
• W2912572866 date "2018-12-15" @default.
• W2912572866 modified "2023-09-27" @default.
• W2912572866 title "Network meta-analysis: a comparison of effectiveness and safety of partial agonists of nicotinic acetylcholine receptors varenicline and cytisine for smoking cessation" @default.
• W2912572866 cites W1547289621 @default.
• W2912572866 cites W1856850049 @default.
• W2912572866 cites W1936223934 @default.
• W2912572866 cites W1965620134 @default.
• W2912572866 cites W1976653331 @default.
• W2912572866 cites W1978524840 @default.
• W2912572866 cites W1984116490 @default.
• W2912572866 cites W1986773132 @default.
• W2912572866 cites W1989367790 @default.
• W2912572866 cites W1990531738 @default.
• W2912572866 cites W1993563487 @default.
• W2912572866 cites W1993729509 @default.
• W2912572866 cites W2002552913 @default.
• W2912572866 cites W2003016875 @default.
• W2912572866 cites W2007091261 @default.
• W2912572866 cites W2008817040 @default.
• W2912572866 cites W2010652471 @default.
• W2912572866 cites W2011246896 @default.
• W2912572866 cites W2011541865 @default.
• W2912572866 cites W2011994674 @default.
• W2912572866 cites W2035097524 @default.
• W2912572866 cites W2038935864 @default.
• W2912572866 cites W2045459335 @default.
• W2912572866 cites W2048021420 @default.
• W2912572866 cites W2048169408 @default.
• W2912572866 cites W2051592959 @default.
• W2912572866 cites W2051618313 @default.
• W2912572866 cites W2052001423 @default.
• W2912572866 cites W2054556459 @default.
• W2912572866 cites W2067760311 @default.
• W2912572866 cites W2069480407 @default.
• W2912572866 cites W2073429128 @default.
• W2912572866 cites W2089345569 @default.
• W2912572866 cites W2093986666 @default.
• W2912572866 cites W2098923148 @default.
• W2912572866 cites W2100204115 @default.
• W2912572866 cites W2106245886 @default.
• W2912572866 cites W2107200746 @default.
• W2912572866 cites W2109535127 @default.
• W2912572866 cites W2113308458 @default.
• W2912572866 cites W2117389430 @default.
• W2912572866 cites W2121369880 @default.
• W2912572866 cites W2123239058 @default.
• W2912572866 cites W2124679681 @default.
• W2912572866 cites W2129372385 @default.
• W2912572866 cites W2132901434 @default.
• W2912572866 cites W2137549318 @default.
• W2912572866 cites W2140516020 @default.
• W2912572866 cites W2141722496 @default.
• W2912572866 cites W2143238807 @default.
• W2912572866 cites W2146257157 @default.
• W2912572866 cites W2152754089 @default.
• W2912572866 cites W2153613936 @default.
• W2912572866 cites W2160498672 @default.
• W2912572866 cites W2164386461 @default.
• W2912572866 cites W2166090261 @default.
• W2912572866 cites W2171686785 @default.
• W2912572866 cites W2171937180 @default.
• W2912572866 cites W2271005668 @default.
• W2912572866 cites W2313894381 @default.
• W2912572866 cites W2340896985 @default.
• W2912572866 cites W2345064511 @default.
• W2912572866 cites W2403101948 @default.
• W2912572866 cites W2507697250 @default.
• W2912572866 cites W2549392623 @default.
• W2912572866 cites W2560831855 @default.
• W2912572866 cites W2589250705 @default.
• W2912572866 cites W2609660229 @default.
• W2912572866 cites W2612997660 @default.
• W2912572866 cites W2614070157 @default.
• W2912572866 cites W2620600515 @default.
• W2912572866 cites W2739356510 @default.
• W2912572866 cites W2755870916 @default.
• W2912572866 cites W2780716234 @default.
• W2912572866 cites W2782450480 @default.
• W2912572866 cites W2796633426 @default.
• W2912572866 cites W2809089067 @default.
• W2912572866 doi "https://doi.org/10.17816/rcf16419-32" @default.
• W2912572866 hasPublicationYear "2018" @default.
• W2912572866 type Work @default.
• W2912572866 sameAs 2912572866 @default.
• W2912572866 citedByCount "0" @default.
• W2912572866 crossrefType "journal-article" @default.
• W2912572866 hasAuthorship W2912572866A5009020541 @default.
• W2912572866 hasAuthorship W2912572866A5009392255 @default.

• next